Use of hepadnavirus core proteins as vaccine platforms
- 1 November 2009
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Vaccines
- Vol. 8 (11) , 1565-1573
- https://doi.org/10.1586/erv.09.121
Abstract
(2009). Use of hepadnavirus core proteins as vaccine platforms. Expert Review of Vaccines: Vol. 8, No. 11, pp. 1565-1573.Keywords
This publication has 86 references indexed in Scilit:
- Interaction of the Hepatitis B Core Antigen and the Innate Immune SystemThe Journal of Immunology, 2009
- Antigenic presentation of heterologous epitopes engineered into the outer surface-exposed helix 4 loop region of human papillomavirus L1 capsomeresVirology Journal, 2009
- Internal Core Protein Cleavage Leaves the Hepatitis B Virus Capsid Intact and Enhances Its Capacity for Surface Display of Heterologous Whole Chain ProteinsPublished by Elsevier ,2008
- Development of a universal influenza A vaccine based on the M2e peptide fused to the papaya mosaic virus (PapMV) vaccine platformVaccine, 2008
- The B Cell Receptor Governs the Subcellular Location of Toll-like Receptor 9 Leading to Hyperresponses to DNA-Containing AntigensImmunity, 2008
- Phase I Trial of an Alhydrogel Adjuvanted Hepatitis B Core Virus-Like Particle Containing Epitopes of Plasmodium falciparum Circumsporozoite ProteinPLOS ONE, 2008
- Contamination of a Recombinant Hepatitis B Virus Nucleocapsid Preparation with a Human B-Cell ActivatorJournal of Virology, 2007
- Advantages to the use of rodent hepadnavirus core proteins as vaccine platformsVaccine, 2007
- The Immune Epitope Database and Analysis Resource: From Vision to BlueprintPLoS Biology, 2005
- Determination of the fold of the core protein of hepatitis B virus by electron cryomicroscopyNature, 1997